Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Go back to Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update| (NASDAQ: TSHA) | Delayed: 6.42 +0.23 (3.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.19 | 52 Week High | $ | |||
| Open | $6.24 | 52 Week Low | $ | |||
| Day High | $6.57 | P/E | N/A | |||
| Day Low | $6.24 | EPS | $ | |||
| Volume | 6,368,908 | |||||

